Literature DB >> 20084476

Interaction of SDF-1alpha and CXCR4 plays an important role in pulmonary cellular infiltration in differentiation syndrome.

Jin Zhou1, Longhu Hu, Zhe Cui, Xian Jiang, Guifang Wang, Geoffrey W Krissansen, Xueying Sun.   

Abstract

This study aims to investigate the role of stromal cell-derived factor 1alpha (SDF-1alpha) and its receptor CXCR4 in cellular infiltration of the lung in differentiation syndrome (DS). The acute promyelocytic leukemia (APL) NB4 cells and freshly prepared APL cells from the patients were differentiated by all-trans retinoic acid (ATRA). The expression of SDF-1alpha in human lung tissues was examined by RT-PCR and Western blot analysis. The cells were subjected to adhesion, migration or invasion assays, and co-cultured with human lung tissues in a microgravity rotary cell culture system to examine cellular infiltration in situ. ATRA-differentiated cells expressed high levels of CXCR4, and adhered more strongly to matrigel. Their ability to migrate and invade was enhanced by SDF-1alpha and lung homogenate, and diminished by pre-treatment with an anti-CXCR4 blocking antibody. SDF-1alpha was expressed in the lung tissues of all seven human donors. ATRA-differentiated NB4 cells infiltrated into lung tissues, and this was reduced by pre-treatment with an anti-CXCR4 blocking antibody. The interaction of SDF-1alpha and CXCR4 plays an important role in pulmonary cellular infiltration during DS, suggesting that targeting SDF-1alpha and CXCR4 may provide the basis for potential treatments in the management of DS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20084476     DOI: 10.1007/s12185-009-0488-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  41 in total

1.  Microgravity potentiates stem cell proliferation while sustaining the capability of differentiation.

Authors:  Louis Yuge; Teruyuki Kajiume; Hidetoshi Tahara; Yumi Kawahara; Chika Umeda; Reiko Yoshimoto; Shu-Liang Wu; Kazuko Yamaoka; Makoto Asashima; Katsuko Kataoka; Toshinori Ide
Journal:  Stem Cells Dev       Date:  2006-12       Impact factor: 3.272

Review 2.  Acute promyelocytic leukemia: biology and treatment.

Authors:  P Fenaux; C Chomienne; L Degos
Journal:  Semin Oncol       Date:  1997-02       Impact factor: 4.929

3.  Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV.

Authors:  Maria Grazia Narducci; Enrico Scala; Antonella Bresin; Elisabetta Caprini; Maria Cristina Picchio; Daniele Remotti; Gianluca Ragone; Francesca Nasorri; Marina Frontani; Diego Arcelli; Stefano Volinia; Giuseppe Alfonso Lombardo; Giannandrea Baliva; Monica Napolitano; Giandomenico Russo
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

4.  Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4.

Authors:  A Peled; I Petit; O Kollet; M Magid; T Ponomaryov; T Byk; A Nagler; H Ben-Hur; A Many; L Shultz; O Lider; R Alon; D Zipori; T Lapidot
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

5.  Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells.

Authors:  Ayelet Dar; Polina Goichberg; Vera Shinder; Alexander Kalinkovich; Orit Kollet; Neta Netzer; Raanan Margalit; Marion Zsak; Arnon Nagler; Izhar Hardan; Igor Resnick; Antal Rot; Tsvee Lapidot
Journal:  Nat Immunol       Date:  2005-09-18       Impact factor: 25.606

6.  CXCR4 is a prognostic marker in acute myelogenous leukemia.

Authors:  Anke C Spoo; Michael Lübbert; William G Wierda; Jan A Burger
Journal:  Blood       Date:  2006-08-03       Impact factor: 22.113

Review 7.  All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia.

Authors:  L Degos; H Dombret; C Chomienne; M T Daniel; J M Micléa; C Chastang; S Castaigne; P Fenaux
Journal:  Blood       Date:  1995-05-15       Impact factor: 22.113

Review 8.  Acute promyelocytic leukemia: from highly fatal to highly curable.

Authors:  Zhen-Yi Wang; Zhu Chen
Journal:  Blood       Date:  2008-03-01       Impact factor: 22.113

Review 9.  SDF-1 and CXCR4 in normal and malignant hematopoiesis.

Authors:  J Juarez; L Bendall
Journal:  Histol Histopathol       Date:  2004-01       Impact factor: 2.303

Review 10.  Acute promyelocytic leukemia.

Authors:  R P Warrell; H de Thé; Z Y Wang; L Degos
Journal:  N Engl J Med       Date:  1993-07-15       Impact factor: 91.245

View more
  5 in total

1.  All-trans-retinoic acid activates SDF-1/CXCR4/ROCK2 signaling pathway to inhibit chondrogenesis.

Authors:  Qin-Xiao Hu; Xue-Dong Li; Peng Xie; Chu-Cheng Wu; Gui-Zhou Zheng; Fei-Xiang Lin; Da Xie; Qi-Hao Zhang; De-Zhong Liu; Yun-Guo Wang; Bo Chang; Shi-Xin Du
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

2.  Modulating the interaction of CXCR4 and CXCL12 by low-molecular-weight heparin inhibits hepatic metastasis of colon cancer.

Authors:  Lixin Ma; Haiquan Qiao; Changjun He; Qian Yang; Chun Hei Antonio Cheung; Jagat R Kanwar; Xueying Sun
Journal:  Invest New Drugs       Date:  2010-11-16       Impact factor: 3.850

Review 3.  Potential role of nuclear receptor ligand all-trans retinoic acids in the treatment of fungal keratitis.

Authors:  Hong-Yan Zhou; Wei Zhong; Hong Zhang; Miao-Miao Bi; Shuang Wang; Wen-Song Zhang
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

4.  Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis.

Authors:  Kelly J Norsworthy; Flora Mulkey; Emma C Scott; Ashley F Ward; Donna Przepiorka; Rosane Charlab; Sarah E Dorff; Albert Deisseroth; Dickran Kazandjian; Rajeshwari Sridhara; Julia A Beaver; Ann T Farrell; R Angelo de Claro; Richard Pazdur
Journal:  Clin Cancer Res       Date:  2020-05-11       Impact factor: 12.531

Review 5.  Role of CXCR4 in the progression and therapy of acute leukaemia.

Authors:  Long Su; Zheng Hu; Yong-Guang Yang
Journal:  Cell Prolif       Date:  2021-05-29       Impact factor: 6.831

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.